As H1N1 Virus Spreads Fast In India, Government Ups Its Offensive
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India's health ministry has gone into hyperactive mode to combat the spread of the A/H1N1 influenza virus. The disease has claimed 14 lives over the last five days, while close to 1,000 more people tested positive and were treated in government-run hospitals
You may also be interested in...
With Shortage Looming Large, Cipla Offers Generic Tamiflu, Relenza To U.S. Health Department
MUMBAI - Known for supplying low-priced anti-retroviral cocktail therapy to frontline African nations to combat the spread of HIV/AIDS, Cipla - India's largest drug maker by market share - is in discussions with U.S. health agencies to boost production of antiviral oseltamivir, the generic for Roche's Tamiflu for treating the rapidly spreading H1N1 virus
With Shortage Looming Large, Cipla Offers Generic Tamiflu, Relenza To U.S. Health Department
MUMBAI - Known for supplying low-priced anti-retroviral cocktail therapy to frontline African nations to combat the spread of HIV/AIDS, Cipla - India's largest drug maker by market share - is in discussions with U.S. health agencies to boost production of antiviral oseltamivir, the generic for Roche's Tamiflu for treating the rapidly spreading H1N1 virus
Roche In Stand-by Mode To Supply Tamifl& To Indian Government; Others Queue Up Too
MUMBAI - As the Indian government grapples with the threat of influenza H1N1 through countrywide moves to stockpile drugs, protective masks and diagnostic kits, Roche India has said it has been approached for supplies of Tamiflu (oseltamivir) by the Indian health ministry but there are no clear orders issued yet to commence supply of the drugs